Could a gel heal parasite skin sores? new study begins

NCT ID NCT07149753

Not yet recruiting Disease control Sponsor: Universidad Industrial de Santander Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This early study tests a gel made with the drug miltefosine for people with uncomplicated cutaneous leishmaniasis, a skin infection from a parasite. Fifteen adults will apply the gel to their sores daily for 28 days. The main goal is to see if the gel is safe and if it helps the sores heal, to decide whether to test it in larger studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: miltefosine gel (applied to the skin)
What this could lead to: If it works, this could lead to a simpler, topical treatment for cutaneous leishmaniasis, avoiding the need for injections or pills.
What could go wrong: This is a very early Phase 1 pilot with only 15 people. It is designed mainly to check safety, not to prove the gel works. The gel may not heal the sores or could cause skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS LEISHMANIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutaneous leishmaniasis mucocutaneous leishmaniasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CUTANEOUS LEISHMANIASIS CUTANEOUS LEISHMANIASIS, AMERICAN TOPICAL ADMINISTRATION

Could a gel heal parasite skin sores? new study begins

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions